IBUPROFEN-QUERCETIN COMBINATION ASA NOVEL PHARMACEUTICAL COMPATIBLE SYSTEM | ||
| Zagazig Journal of Pharmaceutical Sciences | ||
| Article 6, Volume 10, Issue 1, June 2001, Pages 29-33 PDF (2.67 M) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/zjps.2001.181592 | ||
| Authors | ||
| Mohamed Abdel Mohsen* 1; Mahmoud El-Badry1; Osama Soliman2 | ||
| 1Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, Egypt. | ||
| 2Department of Pharmaceutics Faculty of pharmacy. Mansoura University, Mansour. 35516. Egypt. | ||
| Abstract | ||
| The effect of oral administration of quercetin (QRT) (25 mg/kg) on an experimentally Ibuprofen- induced ulcer was studied in rats. The results of gross appearance and scanning electromicrographs of the mucous membrane and superficial cells of the stomach revealed that the quercetin reduced the damage of submucosal superficial cells. Differential scanning calorimetry, X-ray diffractometer, IR spectroscopy, solubility and partitioning studies elucidated the absence of any interaction between the two compounds and also the physical compatibility of ibuprofen (IP)-quercetin combination. It is concluded that ibuprofen and quercetin can be pharmaceutically co-formulated or co-administrated with the aim of reducing the gastrointestinal adverse effects of ibuprofen. | ||
|
Statistics Article View: 271 PDF Download: 75 |
||
